Hydroquinone Topical Cream - Product information and Uses

Hydroquinone, also benzene-1,4-diol or quinol, is an aromatic organic compound that is a type of phenol. It is a white granular solid and occurs as fine white needles. The drug is freely soluble in water and in alcohol with a pKa of 9.96.
Melalite cream is used as a topical application in skin whitening to reduce the color of skin of darkened skin such as freckles, age spots, chloasma, and melasma. Safety and effectiveness of Hydroquinone Topical Cream in pediatric patients below the age of 12 years have not been established.

Hydroquinone Topical Cream - Availability And Packaging

Hydroquinone Topical Cream is available as Melalite Cream which is packaged in Hydroquinone Topical Cream is also available as Aclaro, Alera, Alphaquin HP, Alustra, Claripel, Eldopaque, Eldoquin, Eldoquin Forte, EpiQuin Micro, Esoterica, Glyquin, Glyquin-XM, Hydroquinone cream, Lustra, Melpaque HP, Melquin HP, Melquin-3, Nuquin HP, Solaquin, Melanex, Melanol, Viquin Forte, Esoterica Sensitive Skin, Nava-SC, Remergent HQ, EpiQuin Micro Pump.

Side Effects of Hydroquinone Topical Cream

No systemic reactions have been associated with the use of Hydroquinone Topical Cream. Occasional side effects that may occur are cutaneous hypersensitivity (localized contact dermatitis) . In such cases the medication should be discontinued and the doctor notified.
On rare occasions, a gradual blue-black darkening of the skin may occur. If this takes place discontinue the use of Hydroquinone Topical Cream (Melalite cream)and contact your doctor immediately. Hydroquinone Topical Cream is a depigmenting agent which may produce unwanted cosmetic effects if not used as directed.

Hydroquinone Topical Cream (Melalite Cream) - Dosage

Melalite Cream should be applied to the affected areas twice daily, or as directed by a physician.
There is no recommended dosage for pediatric patients under 12 years of age except under the advice and supervision of a physician.

Warnings and precautions when using Hydroquinone Topical Cream (Melalite Cream)

Test for skin sensitivity before using Melalite Cream by applying a small amount to an unbroken patch of skin and check within 24 hours. Minor redness is not a contraindication, but where there is itching, vesicle formation, or excessive inflammatory response, further treatment is not advised.
Close patient supervision is recommended. Contact with the eyes should be avoided. If no lightening effect is noted after two months of treatment, use of Melalite Cream (Hydroquinone Topical Cream) should be discontinued.
Sunscreen use is an essential aspect of Hydroquinone therapy because even minimal sunlight exposure sustains melanocyte activity. During and after the use of Melalite Cream, sun exposure should be limited or sun-protective clothing should be used to cover the treated areas to prevent repigmentation.
Keep this medication out of the reach of children. In case of accidental ingestion, contact a doctor or poison control center immediately.

Overdosage and Overdose Symptoms of Hydroquinone Topical (Melalite cream)

There have been no systemic reactions reported from the use of topica hydroquinone.
Treatment should be however be limited to relatively small areas of the body at one time, since some patients experience a transient skin reddening and a mild burning sensation which does not preclude treatment.